Whole Exome Sequencing (WES)
The Whole Exome Sequencing Test (WES test) is a powerful genetic testing method that focuses on sequencing the protein-coding regions of the genome—where most known disease-causing mutations occur. It offers critical insights into inherited conditions, rare diseases, and gene-related disorders, supporting personalized medical care.
Conditions Detected by WES
Inherited and rare
genetic disorders
Neurological and
developmental conditions
Cancer susceptibility
genes
Unexplained health issues
with genetic basis
Genome Sequencing Solutions
Why the Whole Exome Sequencing Test Matters
How the WES Test Works
Reveal Hidden Conditions in Three Steps
Sample Collection
Blood or saliva is collected at our facility or via a home collection kit.
Exome Sequencing
Your exome is decoded using next-generation sequencing and advanced bioinformatics tools.
Report & Consultation
Receive a comprehensive report with interpretation and physician-led consultation for clarity and action.
Why Choose FSG for WES
Precision
Technology
We use validated, high-resolution sequencing to ensure accurate detection of genetic variants.
Expert
Team
Board-certified geneticists and molecular experts review every result for clinical relevance.
Rapid
Results
Turnaround times designed to support fast and informed medical decision-making.
Pioneering
Lab
As the UAE’s first certified molecular stem cell and genomics laboratory, FSG sets the standard for whole exome sequencing test services in the region.
Frequently Asked
Questions!
We’re here to help. Explore answers or reach out to our team directly.
The whole exome sequencing test analyzes the protein-coding regions of your DNA, where most known disease-causing mutations occur. It helps detect inherited genetic disorders, rare diseases, neurological conditions, and cancer susceptibility, providing critical insights for diagnosis and personalized medical care.
Exome testing identifies genetic mutations responsible for unexplained symptoms, inherited diseases, and developmental conditions. By focusing only on the exome, which makes up about 1% of the genome but holds 85% of disease-causing mutations, the WES test offers a targeted, efficient, and cost-effective approach to genetic diagnosis.
The reporting time for a whole exome sequencing test usually falls between two and six weeks, based on the analysis required and the specific workflows followed by the testing laboratory. At FSG, we prioritize rapid and accurate reporting to support timely medical decision-making.
The main difference is in the scope. Whole genome sequencing analyzes the entire DNA sequence, while the WES test focuses only on the exons—the protein-coding regions. Exome testing is more targeted and cost-effective, capturing the areas most likely to reveal disease-causing mutations, making it a practical first step for many genetic investigations.
Services
Innovation Stem Cell & Regenerative Medicine Solutions
